Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2018.1500897
Abstract: ABSTRACT Introduction: Allogeneic hematopoietic cell transplants (allo-HCT) recipients are at the high-risk of reactivation of cytomegalovirus (CMV), and reactivation is associated with significant morbidity and mortality. Although available anti-CMV therapies may be effective for the… read more here.
Keywords: cmv; infection; letermovir prevention; cytomegalovirus ... See more keywords